Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy

C. P. D. M. de Breet, S. Zwaveling, M. J. A. Vries, R. G. van Oerle, Y. M. C. Henskens, A. W. J. Van't Hof, P. E. J. van der Meijden, L. Veenstra, H. ten Cate, R. H. Olie*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number679934
Number of pages10
JournalFrontiers in cardiovascular medicine
Volume8
DOIs
Publication statusPublished - 10 Jun 2021

Keywords

  • thrombin generation
  • dual antiplatelet therapy
  • bleeding risk
  • percutaneous coronary intervention
  • coagulation factors
  • CORONARY-ARTERY-DISEASE
  • COAGULATION-FACTORS
  • HEMOPHILIA-A
  • WHOLE-BLOOD
  • PLASMA
  • DETERMINANTS
  • CLOPIDOGREL
  • CAPACITY
  • UPDATE
  • SCORE

Cite this